pI: 7.3821 |
Length (AA): 91 |
MW (Da): 10896 |
Paralog Number:
3
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 90 | 5wby (B) | 2026 | 2115 | 44.00 | 0 | 1 | 1.6707 | -1.46 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_127212)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G50030 | serine/threonine-protein kinase TOR |
Brugia malayi | Bm1_48125 | Phosphatidylinositol 3- and 4-kinase family protein |
Candida albicans | CaO19.9461 | similar to internal region of S. cerevisiae TOR2 (YKL203C) and TOR1 (YJR066W) protein/phosphatidylinositol kinases involved in n |
Candida albicans | CaO19.1903 | frameshifted from upstream TOR2 CDS (CaP19.1905) |
Candida albicans | CaO19.9459 | frameshifted from upsteam TOR2 CDS (CaP19.9461) |
Candida albicans | CaO19.1905 | similar to internal region of S. cerevisiae TOR2 (YKL203C) and TOR1 (YJR066W) protein/phosphatidylinositol kinases involved in n |
Candida albicans | CaO19.9830 | similar to N terminal region of S. cerevisiae TOR2 (YKL203C) and TOR1 (YJR066W) putative protein/phosphatidylinositol kinases in |
Candida albicans | CaO19.2290 | similar to N terminal region of S. cerevisiae TOR2 (YKL203C) and TOR1 (YJR066W) putative protein/phosphatidylinositol kinases in |
Caenorhabditis elegans | CELE_B0261.2 | Protein LET-363, isoform A |
Dictyostelium discoideum | DDB_G0281569 | FRAP subfamily protein kinase |
Drosophila melanogaster | Dmel_CG5092 | Target of rapamycin |
Echinococcus granulosus | EgrG_000787900 | FKBP12 rapamycin complex associated protein |
Entamoeba histolytica | EHI_155160 | FKBP-rapamycin associated protein (FRAP), putative |
Entamoeba histolytica | EHI_169320 | phosphatidylinositol3-kinaseTor2, putative |
Echinococcus multilocularis | EmuJ_000787900 | FKBP12 rapamycin complex associated protein |
Giardia lamblia | GL50803_35180 | GTOR |
Homo sapiens | ENSG00000198793 | mechanistic target of rapamycin (serine/threonine kinase) |
Leishmania braziliensis | LbrM.20.3990 | target of rapamycin (TOR) kinase 2, putative |
Leishmania donovani | LdBPK_366580.1 | Phosphatidylinositol 3-kinase tor1 |
Leishmania donovani | LdBPK_344160.1 | Phosphatidylinositol 3-kinase tor2 |
Leishmania infantum | LinJ.36.6580 | target of rapamycin (TOR) kinase 1, putative |
Leishmania infantum | LinJ.34.4160 | target of rapamycin (TOR) kinase 2, putative |
Leishmania major | LmjF.36.6320 | target of rapamycin (TOR) kinase 1, putative |
Leishmania major | LmjF.34.4530 | target of rapamycin (TOR) kinase 2, putative |
Leishmania mexicana | LmxM.33.4530 | phosphatidylinositol 3-kinase (tor2)-like protein |
Leishmania mexicana | LmxM.36.6320 | phosphatidylinositol 3 kinase, putative |
Loa Loa (eye worm) | LOAG_06798 | phosphatidylinositol 3 |
Loa Loa (eye worm) | LOAG_11192 | hypothetical protein |
Mus musculus | ENSMUSG00000028991 | mechanistic target of rapamycin (serine/threonine kinase) |
Neospora caninum | NCLIV_058910 | Phosphatidylinositol 3-kinase tor2, related |
Oryza sativa | 4338174 | Os05g0235300 |
Saccharomyces cerevisiae | YJR066W | phosphatidylinositol kinase-related protein kinase TOR1 |
Saccharomyces cerevisiae | YKL203C | phosphatidylinositol kinase-related protein kinase TOR2 |
Schistosoma japonicum | Sjp_0134370 | FKBP12-rapamycin complex-associated protein, putative |
Schistosoma japonicum | Sjp_0089220 | ko:K07203 FKBP12-rapamycin complex-associated protein, putative |
Schistosoma japonicum | Sjp_0131090 | FKBP12-rapamycin complex-associated protein, putative |
Schistosoma japonicum | Sjp_0215970 | FKBP12-rapamycin complex-associated protein, putative |
Schistosoma mansoni | Smp_122910 | ataxia telangiectasia mutated (atm)-related |
Schmidtea mediterranea | mk4.000497.09 | |
Schmidtea mediterranea | mk4.000497.07 | |
Schmidtea mediterranea | mk4.000497.08 | |
Schmidtea mediterranea | mk4.000497.05 | Tor-like protein |
Trypanosoma brucei gambiense | Tbg972.4.150 | phosphatidylinositol 3-kinase tor, putative |
Trypanosoma brucei gambiense | Tbg972.10.10260 | phosphatidylinositol 3 kinase, putative |
Trypanosoma brucei | Tb927.10.8420 | Phosphatidylinositol 3-kinase tor1 |
Trypanosoma brucei | Tb927.4.420 | phosphatidylinositol 4-kinase, putative |
Trypanosoma brucei | Tb11.v5.0744 | phosphatidylinositol 3-kinase tor, putative |
Trypanosoma congolense | TcIL3000_4_110 | Phosphatidylinositol 3-kinase tor2 |
Trypanosoma congolense | TcIL3000_10_7280 | Phosphatidylinositol 3-kinase tor1 |
Trypanosoma cruzi | TcCLB.510689.40 | Phosphatidylinositol 3-kinase tor2 |
Trypanosoma cruzi | TcCLB.508231.30 | Phosphatidylinositol 3-kinase tor1 |
Toxoplasma gondii | TGME49_316430 | target of rapamycin (TOR), putative |
Trichomonas vaginalis | TVAG_346960 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_422770 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_163840 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_305430 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_271190 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_490020 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_069490 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_451890 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_445310 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_040340 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_232830 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_327580 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_235060 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_068860 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_359910 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_239190 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_412960 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_257180 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_087200 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_197350 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_405500 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_453520 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_125480 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_392220 | PIKK family atypical protein kinase |
Trichomonas vaginalis | TVAG_212750 | PIKK family atypical protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.4.420 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.4.420 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.4.420 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.4.420 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.10.8420 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.8420 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.8420 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.8420 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_B0261.2 | Caenorhabditis elegans | embryonic arrest | wormbase |
CELE_B0261.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_B0261.2 | Caenorhabditis elegans | larval arrest | wormbase |
YKL203C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_316430 | Toxoplasma gondii | Probably non-essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | mechanistic target of rapamycin (serine/threonine kinase) | Compounds | References |
Mus musculus | mechanistic target of rapamycin (serine/threonine kinase) | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase mTOR | Compounds | References |